Literature DB >> 10069470

Expression cloning for arsenite-resistance resulted in isolation of tumor-suppressor fau cDNA: possible involvement of the ubiquitin system in arsenic carcinogenesis.

T G Rossman1, Z Wang.   

Abstract

Arsenic is a human carcinogen whose mechanism of action is unknown. Previously, this laboratory demonstrated that arsenite acts as a comutagen by interfering with DNA repair, although a specific DNA repair enzyme sensitive to arsenite has not been identified. A number of stable arsenite-sensitive and arsenite-resistant sublines of Chinese hamster V79 cells have now been isolated. In order to gain understanding of possible targets for arsenite's action, one arsenite-resistant subline, As/R28A, was chosen as a donor for a cDNA expression library. The library from arsenite-induced As/R28A cells was transfected into arsenite-sensitive As/S5 cells, and transfectants were selected for arsenite-resistance. Two cDNAs, asr1 and asr2, which confer arsenite resistance to arsenite-hypersensitive As/S5 cells as well as to wild-type cells, were isolated. asr1 shows almost complete homology with the rat fau gene, a tumor suppressor gene which contains a ubiquitin-like region fused to S30 ribosomal protein. Arsenite was previously shown to inhibit ubiquitin-dependent proteolysis. These results suggest that the tumor suppressor fau gene product or some other aspect of the ubiquitin system may be a target for arsenic toxicity and that disruption of the ubiquitin system may contribute to the genotoxicity and carcinogenicity of arsenite.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10069470     DOI: 10.1093/carcin/20.2.311

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  17 in total

1.  Ars2 links the nuclear cap-binding complex to RNA interference and cell proliferation.

Authors:  Joshua J Gruber; D Steven Zatechka; Leah R Sabin; Jeongsik Yong; Julian J Lum; Mei Kong; Wei-Xing Zong; Zhenxi Zhang; Chi-Kong Lau; Jason Rawlings; Sara Cherry; James N Ihle; Gideon Dreyfuss; Craig B Thompson
Journal:  Cell       Date:  2009-07-23       Impact factor: 41.582

2.  Comparative analysis of the gene-dense ACHE/TFR2 region on human chromosome 7q22 with the orthologous region on mouse chromosome 5.

Authors:  M D Wilson; C Riemer; D W Martindale; P Schnupf; A P Boright; T L Cheung; D M Hardy; S Schwartz; S W Scherer; L C Tsui; W Miller; B F Koop
Journal:  Nucleic Acids Res       Date:  2001-03-15       Impact factor: 16.971

3.  Ars2 promotes proper replication-dependent histone mRNA 3' end formation.

Authors:  Joshua J Gruber; Scott H Olejniczak; Jeongsik Yong; Gaspare La Rocca; Gideon Dreyfuss; Craig B Thompson
Journal:  Mol Cell       Date:  2012-01-13       Impact factor: 17.970

4.  The arabidopsis serrate gene encodes a zinc-finger protein required for normal shoot development.

Authors:  M J Prigge; D R Wagner
Journal:  Plant Cell       Date:  2001-06       Impact factor: 11.277

5.  2,3,5,6-Tetramethylpyrazine (TMP) down-regulated arsenic-induced heme oxygenase-1 and ARS2 expression by inhibiting Nrf2, NF-κB, AP-1 and MAPK pathways in human proximal tubular cells.

Authors:  Xuezhong Gong; Vladimir N Ivanov; Tom K Hei
Journal:  Arch Toxicol       Date:  2015-09-24       Impact factor: 5.153

6.  Genomic dissection reveals locus response to stress for mammalian acetylcholinesterase.

Authors:  A D Grant; M Shapira; H Soreq
Journal:  Cell Mol Neurobiol       Date:  2001-12       Impact factor: 5.046

7.  A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia.

Authors:  Qun-Ye Zhang; Jian-Hua Mao; Ping Liu; Qiu-Hua Huang; Jing Lu; Yin-Yin Xie; Lin Weng; Yan Zhang; Quan Chen; Sai-Juan Chen; Zhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

8.  The RNA binding protein Ars2 supports hematopoiesis at multiple levels.

Authors:  Seerat Elahi; Shawn M Egan; G Aaron Holling; Rachel L Kandefer; Michael J Nemeth; Scott H Olejniczak
Journal:  Exp Hematol       Date:  2018-05-15       Impact factor: 3.084

9.  Interaction of FLASH with arsenite resistance protein 2 is involved in cell cycle progression at S phase.

Authors:  Maria Kiriyama; Yohei Kobayashi; Motoki Saito; Fuyuki Ishikawa; Shin Yonehara
Journal:  Mol Cell Biol       Date:  2009-06-22       Impact factor: 4.272

10.  Dysregulated expression of Fau and MELK is associated with poor prognosis in breast cancer.

Authors:  Mark R Pickard; Andrew R Green; Ian O Ellis; Carlos Caldas; Vanessa L Hedge; Mirna Mourtada-Maarabouni; Gwyn T Williams
Journal:  Breast Cancer Res       Date:  2009-08-11       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.